Ashita Debnath

Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive…

American Journal of Health-System Pharmacy · 2024 · 7 citations

Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections

Annals of Pharmacotherapy · 2023 · First of 6 authors · 3 citations